Correlation Between Sanofi ADR and Merck

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Sanofi ADR and Merck at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sanofi ADR and Merck into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Sanofi ADR and Merck Company, you can compare the effects of market volatilities on Sanofi ADR and Merck and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sanofi ADR with a short position of Merck. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sanofi ADR and Merck.

Diversification Opportunities for Sanofi ADR and Merck

-0.48
  Correlation Coefficient

Very good diversification

The 3 months correlation between Sanofi and Merck is -0.48. Overlapping area represents the amount of risk that can be diversified away by holding Sanofi ADR and Merck Company in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Merck Company and Sanofi ADR is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sanofi ADR are associated (or correlated) with Merck. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Merck Company has no effect on the direction of Sanofi ADR i.e., Sanofi ADR and Merck go up and down completely randomly.

Pair Corralation between Sanofi ADR and Merck

Considering the 90-day investment horizon Sanofi ADR is expected to generate 0.76 times more return on investment than Merck. However, Sanofi ADR is 1.32 times less risky than Merck. It trades about 0.16 of its potential returns per unit of risk. Merck Company is currently generating about -0.08 per unit of risk. If you would invest  4,823  in Sanofi ADR on December 28, 2024 and sell it today you would earn a total of  668.00  from holding Sanofi ADR or generate 13.85% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Sanofi ADR  vs.  Merck Company

 Performance 
       Timeline  
Sanofi ADR 

Risk-Adjusted Performance

Good

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Sanofi ADR are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unfluctuating basic indicators, Sanofi ADR showed solid returns over the last few months and may actually be approaching a breakup point.
Merck Company 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Merck Company has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest uncertain performance, the Stock's basic indicators remain persistent and the latest mess on Wall Street may also be a sign of long-standing gains for the company institutional investors.

Sanofi ADR and Merck Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Sanofi ADR and Merck

The main advantage of trading using opposite Sanofi ADR and Merck positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sanofi ADR position performs unexpectedly, Merck can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Merck will offset losses from the drop in Merck's long position.
The idea behind Sanofi ADR and Merck Company pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.

Other Complementary Tools

Equity Valuation
Check real value of public entities based on technical and fundamental data
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum